Back to top

DexCom resumed with a Buy at UBS

UBS resumed coverage of DexCom (DXCM) with a Buy rating and $96 price target DexCom’s turnaround momentum can continue as expectations reset and CG...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

DexCom, Inc. (DXCM)